329 related articles for article (PubMed ID: 3301606)
1. Cisapride: influence on oesophageal and gastric emptying and gastro-oesophageal reflux in patients with reflux oesophagitis.
Collins BJ; Spence RA; Ferguson R; Laird J; Love AH
Hepatogastroenterology; 1987 Jun; 34(3):113-6. PubMed ID: 3301606
[TBL] [Abstract][Full Text] [Related]
2. Relationship between acceleration of gastric emptying and oesophageal acid exposure in patients with endoscopy-negative gastro-oesophageal reflux disease.
Carmagnola S; Fraquelli M; Cantù P; Conte D; Penagini R
Scand J Gastroenterol; 2006 Jul; 41(7):767-72. PubMed ID: 16785188
[TBL] [Abstract][Full Text] [Related]
3. Influence of cisapride on food-stimulated gastro-oesophageal reflux: a radiological study.
Gelineck J; Aksglade K; Funch-Jensen P; Thommesen P
Rontgenblatter; 1990 Aug; 43(8):352-4. PubMed ID: 2204995
[TBL] [Abstract][Full Text] [Related]
4. [Results of the treatment of gastroesophageal reflux and peptic esophagitis using cisapride].
Carrasco Gandía S; Lama Moré R; Prieto Bozano G; Polanco Allue I
An Esp Pediatr; 1990 Jun; 32(6):485-8. PubMed ID: 2221622
[TBL] [Abstract][Full Text] [Related]
5. Cisapride for gastro-oesophageal reflux and peptic oesophagitis.
Cucchiara S; Staiano A; Capozzi C; Di Lorenzo C; Boccieri A; Auricchio S
Arch Dis Child; 1987 May; 62(5):454-7. PubMed ID: 3300570
[TBL] [Abstract][Full Text] [Related]
6. Effect of cisapride on nocturnal transient lower oesophageal sphincter relaxations and nocturnal gastro-oesophageal reflux in patients with oesophagitis: a double-blind, placebo-controlled study.
Pehlivanov N; Sarosiek I; Whitman R; Olyaee M; McCallum R
Aliment Pharmacol Ther; 2002 Apr; 16(4):743-7. PubMed ID: 11929392
[TBL] [Abstract][Full Text] [Related]
7. Cisapride in the treatment of gastro-oesophageal reflux disease.
Robertson CS; Evans DF; Ledingham SJ; Atkinson M
Aliment Pharmacol Ther; 1993 Apr; 7(2):181-90. PubMed ID: 8485271
[TBL] [Abstract][Full Text] [Related]
8. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS
Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
[TBL] [Abstract][Full Text] [Related]
9. Chronic oral treatment with cisapride decreases high bile salt reflux rates.
Müller-Lissner SA; Fraass C
Am J Gastroenterol; 1986 May; 81(5):354-7. PubMed ID: 3518407
[TBL] [Abstract][Full Text] [Related]
10. Cisapride inhibits meal-stimulated gastric acid secretion and post-prandial gastric acidity in subjects with gastro-oesophageal reflux disease.
Gardner JD; Rodriguez-Stanley S; Robinson M; Miner PB
Aliment Pharmacol Ther; 2002 Oct; 16(10):1819-29. PubMed ID: 12269977
[TBL] [Abstract][Full Text] [Related]
11. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
McKenna CJ; Mills JG; Goodwin C; Wood JR
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711
[TBL] [Abstract][Full Text] [Related]
12. Effect of cisapride on delayed gastric emptying in gastro-oesophageal reflux disease.
Maddern GJ; Jamieson GG; Myers JC; Collins PJ
Gut; 1991 May; 32(5):470-4. PubMed ID: 2040466
[TBL] [Abstract][Full Text] [Related]
13. Effect of cisapride on oesophageal motility and duodenogastro-oesophageal reflux in patients with Barrett's oesophagus.
Smythe A; Bird NC; Troy GP; Globe J; Johnson AG
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1149-53. PubMed ID: 9471019
[TBL] [Abstract][Full Text] [Related]
14. Treatment of gastro-oesophageal reflux and gastric stasis: new perspectives with cisapride. Proceedings of a symposium of the 13th International Congress of Gastroenterology. Rome, 6 September 1988.
Scand J Gastroenterol Suppl; 1989; 165():1-65. PubMed ID: 2602909
[No Abstract] [Full Text] [Related]
15. Cisapride versus ranitidine in the treatment of reflux esophagitis.
Janisch HD; Hüttemann W; Bouzo MH
Hepatogastroenterology; 1988 Jun; 35(3):125-7. PubMed ID: 3042576
[TBL] [Abstract][Full Text] [Related]
16. Effect of cisapride on gastric emptying in patients with gastro-oesophageal reflux disease.
Koruk M; Yildirim M; Onuk MD; Varoğlu E
J Int Med Res; 2001; 29(5):389-91. PubMed ID: 11725825
[TBL] [Abstract][Full Text] [Related]
17. Cisapride for gastroesophageal reflux disease: a placebo-controlled, double-blind study.
Richter JE; Long JF
Am J Gastroenterol; 1995 Mar; 90(3):423-30. PubMed ID: 7872282
[TBL] [Abstract][Full Text] [Related]
18. Primary gastro-oesophageal reflux disease and irritable oesophagus syndrome as causes of recurrent abdominal pain in children.
Corrado G; Cavaliere M; Frandina G; Rea P; Pacchiarotti C; Capocaccia P; Cardi E
Ital J Gastroenterol; 1996; 28(8):462-9. PubMed ID: 9032590
[TBL] [Abstract][Full Text] [Related]
19. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
Miner PB
Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
[TBL] [Abstract][Full Text] [Related]
20. A double-blind placebo-controlled study on prophylactic use of cisapride on feed intolerance and gastric emptying in preterm neonates.
Reddy PS; Deorari AK; Bal CS; Paul VK; Singh M
Indian Pediatr; 2000 Aug; 37(8):837-44. PubMed ID: 10951632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
